Literature DB >> 7592183

Antimicrobial susceptibility of penicillin-sensitive and penicillin-resistant meningococci.

F J Abadi1, D E Yakubu, T H Pennington.   

Abstract

Ceftriaxone showed high in-vitro activity against 119 penicillin-sensitive, penicillin-resistant and rifampicin-resistant UK isolates of meningococci. Unlike ciprofloxacin and minocycline, ceftriaxone is suitable for use in young children or in pregnancy and should be considered for therapy or prophylaxis in an outbreak of meningococcal disease. The E test gave results comparable to those given by broth microdilution method in the determination of meningococcal susceptibility to antimicrobials. It is convenient for use in small laboratories and can be used to determine antimicrobial subgroups of meningococci.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592183     DOI: 10.1093/jac/35.5.687

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Unreliability of disc diffusion test for screening for reduced penicillin susceptibility in Neisseria meningitidis.

Authors:  C Block; Y Davidson; N Keller
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

2.  [Standardization of the Neisseria meningitidis antibiogram. Detection of strains relatively resistant to penicillin].

Authors:  P Nicolas; J D Cavallo; R Fabre; G Martet
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

Review 3.  Community acquired infections and bacterial resistance.

Authors:  H Goossens; M J Sprenger
Journal:  BMJ       Date:  1998-09-05

Review 4.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Rifampin resistance in Neisseria meningitidis due to alterations in membrane permeability.

Authors:  F J Abadi; P E Carter; P Cash; T H Pennington
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.